Education
About Us
Working with TipRanks
Follow Us
ChitogenX (TSE:CHGX)
:CHGX
CHGX Stock Chart & Stats
C$0.01
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.01
C$0.00(0.00%)
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.03
Previous CloseN/A
Volume7.01K
Average Volume (3M)0.00
Market Cap
C$415.65K
Enterprise ValueC$4.60M
Total Cash (Recent Filing)C$48.00K
Total Debt (Recent Filing)C$4.23M
Price to Earnings (P/E)―
Beta0.38
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding83,129,520
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ChitogenX News
CHGX FAQ
What was ChitogenX’s price range in the past 12 months?
ChitogenX lowest stock price was <C$0.01 and its highest was C$0.03 in the past 12 months.
What is ChitogenX’s market cap?
ChitogenX’s market cap is C$415.65K.
When is ChitogenX’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ChitogenX’s earnings last quarter?
Currently, no data Available
Is ChitogenX overvalued?
According to Wall Street analysts ChitogenX’s price is currently Overvalued.
Does ChitogenX pay dividends?
ChitogenX does not currently pay dividends.
What is ChitogenX’s EPS estimate?
ChitogenX’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ChitogenX have?
ChitogenX has 83,129,520 shares outstanding.
What happened to ChitogenX’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ChitogenX?
Currently, no hedge funds are holding shares in TSE:CHGX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ChitogenX
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
Technical Analysis
Covalon Technologies
―
Hemostemix
―
Kane Biotech
―
Microbix Biosystms
―
Quest Pharmatech
―